A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]-Pevonedistat in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs Pevonedistat (Primary) ; Carboplatin; Docetaxel; Paclitaxel
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Takeda Oncology
- 23 May 2017 Study design has changed from double-blind to open.
- 23 May 2017 Status changed from not yet recruiting to recruiting.
- 11 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 15 May 2017.